Evidence map›Paper›PMID 41973914›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Glassy interphases reinforce elastomeric nanocomposites by enhancing volume expansion under strain.

Pierre Kawak, Harshad Bhapkar, David S Simmons

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Glassy interphases reinforce elastomeric nanocomposites by enhancing volume expansion under strain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pierre KawakDepartment of Chemical, Biological, and Materials Engineering, University of South Florida, Tampa, FL 33612.ORCID 0000-0002-5912-7589
Harshad BhapkarDepartment of Chemical, Biological, and Materials Engineering, University of South Florida, Tampa, FL 33612.
David S SimmonsDepartment of Chemical, Biological, and Materials Engineering, University of South Florida, Tampa, FL 33612.ORCID 0000-0002-1436-9269

Funding

DOE | SC | Basic Energy Sciences (BES) DE-SC0022329
6 · The paper itself

Abstract

For nearly a century, introduction of nanoparticles to elastomers has yielded extraordinarily tough nanocomposites that are critical to technologies from actuators to tires. The mechanisms by which this reinforcement occurs have nevertheless remained a central open question in material science. One widely debated hypothesis posits that strong interactions between polymer and particles induce "glassy bridges" that cement particles into a cohesive percolating network that resists elongation. Here, molecular dynamics simulations show that glassy particle shells do not primarily provide elongational cohesion. Instead, they amplify an underlying mechanism wherein competition between filler and elastomer networks causes the elastomer's volume to increase on deformation. This induces contributions from the elastomer's bulk modulus, which is of order 1,000 times larger than its Young's modulus. These findings establish a unified understanding of low-strain reinforcement in filled elastomers as emanating from volumetric competition between coexisting particulate and elastomeric networks. This reframes and unifies our understanding of low-strain reinforcement, provides a clear-cut diagnostic for the presence of glassy bridging, and offers a design principle for tough elastomeric nanocomposites.

Indexed as

elastomersglass transitioninterfacial dynamicsmechanical reinforcementpolymer nanocomposites

Identifiers

PMID41973914
PMCPMC13099608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.